Literature DB >> 21930984

Postoperative clinical radiosensitivity in patients with fanconi anemia and head and neck squamous cell carcinoma.

Andrew C Birkeland1, Arleen D Auerbach, Erica Sanborn, Bhupesh Parashar, William I Kuhel, Settara C Chandrasekharappa, Agata Smogorzewska, David I Kutler.   

Abstract

OBJECTIVE: To describe the complications and adverse effects of postoperative radiotherapy in patients with Fanconi anemia (FA).
DESIGN: Cohort study.
SETTING: Patients with FA treated at community and tertiary care hospitals throughout the United States. PATIENTS: The study included patients with FA who were enrolled in the International FA Registry (IFAR) and who developed head and neck squamous cell carcinoma and received postoperative radiotherapy. MAIN OUTCOME MEASURES: Demographics of patients with FA and adverse effects and dosages of radiotherapy.
RESULTS: Twelve patients with FA (7 men and 5 women) were identified. They developed cancers at a mean age of 35.5 years (age range, 20-48 years). The sites of primary cancer were the oral cavity (n = 8), larynx (n = 2), pharynx (n = 1), and unknown (n = 1). The median radiation dose was 5590 cGy (range, 2500-7020 cGy). The most common adverse effects were mucositis (n = 9), dysphagia (n = 8), and pancytopenia (n = 6). Other complications included esophageal stenosis, laryngeal edema, and wound breakdown. Radiotherapy could not be completed in 5 cases. Overall, 8 patients died, 4 during the course of radiotherapy. The postoperative disease-free survival time ranged from 0 to 55 months.
CONCLUSIONS: Patients with FA have a high rate of complications from radiotherapy. Common adverse effects, particularly mucositis, are especially prevalent and difficult to manage in this population. Pancytopenia is common and may lead to further complications, particularly bleeding and infection. Overall survival is poor. Further study of the response to radiotherapy in patients with FA should be attempted to establish appropriate dosages to balance treating disease while limiting adverse effects.

Entities:  

Mesh:

Year:  2011        PMID: 21930984      PMCID: PMC3343719          DOI: 10.1001/archoto.2011.154

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  19 in total

1.  Normal cellular radiosensitivity in an adult Fanconi anaemia patient with marked clinical radiosensitivity.

Authors:  Y Marcou; A D'Andrea; P A Jeggo; P N Plowman
Journal:  Radiother Oncol       Date:  2001-07       Impact factor: 6.280

2.  Fanconi's anaemia and post-cricoid carcinoma.

Authors:  D G Snow; J B Campbell; L A Smallman
Journal:  J Laryngol Otol       Date:  1991-02       Impact factor: 1.469

3.  Squamous cell carcinoma of the mandible in Franconi anemia: report of case.

Authors:  A S Vaitiekaitis; W H Grau
Journal:  J Oral Surg       Date:  1980-05

4.  Evaluation of the dose for postoperative radiation therapy of head and neck cancer: first report of a prospective randomized trial.

Authors:  L J Peters; H Goepfert; K K Ang; R M Byers; M H Maor; O Guillamondegui; W H Morrison; R S Weber; A S Garden; R A Frankenthaler
Journal:  Int J Radiat Oncol Biol Phys       Date:  1993-04-30       Impact factor: 7.038

5.  Acute graft-versus-host disease in patients with Fanconi anemia or acquired aplastic anemia undergoing bone marrow transplantation from HLA-identical sibling donors: risk factors and influence on outcome.

Authors:  Philippe Guardiola; Gérard Socié; Xiaxin Li; Patricia Ribaud; Agnés Devergie; Hélène Espérou; Patrice Richard; Richard Traineau; Anne Janin; Eliane Gluckman
Journal:  Blood       Date:  2003-08-28       Impact factor: 22.113

Review 6.  Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review.

Authors:  Andy Trotti; Lisa A Bellm; Joel B Epstein; Diana Frame; Henry J Fuchs; Clement K Gwede; Eugene Komaroff; Luba Nalysnyk; Marya D Zilberberg
Journal:  Radiother Oncol       Date:  2003-03       Impact factor: 6.280

Review 7.  Cancer in Fanconi anemia, 1927-2001.

Authors:  Blanche P Alter
Journal:  Cancer       Date:  2003-01-15       Impact factor: 6.860

8.  Fanconi's anemia and clinical radiosensitivity report on two adult patients with locally advanced solid tumors treated by radiotherapy.

Authors:  Michael Bremer; Detlev Schindler; Michaela Gross; Thilo Dörk; Susanne Morlot; Johann H Karstens
Journal:  Strahlenther Onkol       Date:  2003-11       Impact factor: 3.621

9.  A 20-year perspective on the International Fanconi Anemia Registry (IFAR).

Authors:  David I Kutler; Bhuvanesh Singh; Jaya Satagopan; Sat Dev Batish; Marianne Berwick; Philip F Giampietro; Helmut Hanenberg; Arleen D Auerbach
Journal:  Blood       Date:  2002-09-26       Impact factor: 22.113

10.  High incidence of head and neck squamous cell carcinoma in patients with Fanconi anemia.

Authors:  David I Kutler; Arleen D Auerbach; Jaya Satagopan; Philip F Giampietro; Sat Dev Batish; Andrew G Huvos; Andy Goberdhan; Jatin P Shah; Bhuvanesh Singh
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2003-01
View more
  19 in total

Review 1.  Squamous cell carcinomas of the head and neck in Fanconi anemia: risk, prevention, therapy, and the need for guidelines.

Authors:  K Scheckenbach; M Wagenmann; M Freund; J Schipper; H Hanenberg
Journal:  Klin Padiatr       Date:  2012-04-13       Impact factor: 1.349

2.  Programmable bio-nanochip-based cytologic testing of oral potentially malignant disorders in Fanconi anemia.

Authors:  P N Floriano; T Abram; L Taylor; C Le; H Talavera; M Nguyen; R Raja; A Gillenwater; J McDevitt; N Vigneswaran
Journal:  Oral Dis       Date:  2015-04-06       Impact factor: 3.511

3.  Hypersensitivity to chemoradiation in FANCA carrier with cervical carcinoma-A case report and review of the literature.

Authors:  Igor Sirák; Zuzana Šinkorová; Mária Šenkeříková; Jiří Špaček; Jan Laco; Hana Vošmiková; Stanislav John; Jiří Petera
Journal:  Rep Pract Oncol Radiother       Date:  2014-12-05

4.  Intraoral Mitochondrial-Targeted GS-Nitroxide, JP4-039, Radioprotects Normal Tissue in Tumor-Bearing Radiosensitive Fancd2(-/-) (C57BL/6) Mice.

Authors:  Ashwin Shinde; Hebist Berhane; Byung Han Rhieu; Ronny Kalash; Karen Xu; Julie Goff; Michael W Epperly; Darcy Franicola; Xichen Zhang; Tracy Dixon; Donna Shields; Hong Wang; Peter Wipf; Kalindi Parmar; Eva Guinan; Valerian Kagan; Vladimir Tyurin; Robert L Ferris; Xiaolan Zhang; Song Li; Joel S Greenberger
Journal:  Radiat Res       Date:  2016-01-20       Impact factor: 2.841

5.  Acquisition of Relative Interstrand Crosslinker Resistance and PARP Inhibitor Sensitivity in Fanconi Anemia Head and Neck Cancers.

Authors:  Anne J Lombardi; Elizabeth E Hoskins; Grant D Foglesong; Kathryn A Wikenheiser-Brokamp; Lisa Wiesmüller; Helmut Hanenberg; Paul R Andreassen; Allison J Jacobs; Susan B Olson; Winifred W Keeble; Laura E Hays; Susanne I Wells
Journal:  Clin Cancer Res       Date:  2015-01-21       Impact factor: 12.531

6.  Amelioration of radiation-induced oral cavity mucositis and distant bone marrow suppression in fanconi anemia Fancd2-/- (FVB/N) mice by intraoral GS-nitroxide JP4-039.

Authors:  Hebist Berhane; Ashwin Shinde; Ronny Kalash; Karen Xu; Michael W Epperly; Julie Goff; Darcy Franicola; Xichen Zhang; Tracy Dixon; Donna Shields; Hong Wang; Peter Wipf; Song Li; Xiang Gao; Joel S Greenberger
Journal:  Radiat Res       Date:  2014-06-16       Impact factor: 2.841

7.  Massively parallel sequencing, aCGH, and RNA-Seq technologies provide a comprehensive molecular diagnosis of Fanconi anemia.

Authors:  Settara C Chandrasekharappa; Francis P Lach; Danielle C Kimble; Aparna Kamat; Jamie K Teer; Frank X Donovan; Elizabeth Flynn; Shurjo K Sen; Supawat Thongthip; Erica Sanborn; Agata Smogorzewska; Arleen D Auerbach; Elaine A Ostrander
Journal:  Blood       Date:  2013-04-23       Impact factor: 22.113

Review 8.  The Fanconi anemia pathway: repairing the link between DNA damage and squamous cell carcinoma.

Authors:  Lindsey E Romick-Rosendale; Vivian W Y Lui; Jennifer R Grandis; Susanne I Wells
Journal:  Mutat Res       Date:  2013-01-17       Impact factor: 2.433

9.  Amelioration of Head and Neck Radiation-Induced Mucositis and Distant Marrow Suppression in Fanca-/- and Fancg-/- Mice by Intraoral Administration of GS-Nitroxide (JP4-039).

Authors:  John Willis; Michael W Epperly; Renee Fisher; Xichen Zhang; Donna Shields; Wen Hou; Hong Wang; Song Li; Peter Wipf; Kalindi Parmar; Eva Guinan; Justin Steinman; Joel S Greenberger
Journal:  Radiat Res       Date:  2018-03-27       Impact factor: 2.841

10.  Amelioration of Mucositis in Proton Therapy of Fanconi Anemia Fanca-/- Mice by JP4-039.

Authors:  Thomas J Quinn; Xuanfeng Ding; Xiaoqiang Li; George D Wilson; Katie Buelow; Aranee Sivananthan; Stephanie Thermozier; Andrew Henderson; Michael W Epperly; Darcy Franicola; Peter Wipf; Joel S Greenberger; Craig W Stevens; Peyman Kabolizadeh
Journal:  In Vivo       Date:  2019 Nov-Dec       Impact factor: 2.155

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.